Join Peter Diamandis for a Behind-The-Scenes Look at the Companies and Breakthroughs Extending Human Healthspan Today
Extending your lifespan is not only possible, it's starting to accelerate rapidly now.
In this session, Peter reveals the latest insights from his Longevity Metatrends 2026-2035 Report and introduces you to the leading companies and experts driving this change, helping you benefit personally and financially from this exploding $38 trillion market.
YOU SHOULD WATCH IF INTERESTED IN:
INVESTMENT ACCESS
Direct entry to pre-market opportunities in the most compelling biotech sector of the decade. Meet founders, evaluate technologies, and secure allocations in breakthrough startups before they reach mainstream investors.
HEALTH OPTIMIZATION
Personalized pathways to address specific health conditions for yourself or loved ones. Gain privileged access to advanced diagnostics, clinical trials, and emerging therapeutics typically unavailable to the public.
TRANSFORMATIVE INSIGHTS
Engage in private conversations with Harvard researchers, biotech visionaries, and Nobel laureates leading the longevity revolution. These relationships become part of your ongoing journey.
About Your Host
PETER H. DIAMANDIS, MD
Peter H. Diamandis, MD is a serial entrepreneur, futurist, New York Times bestselling author, and founder of over 28 companies spanning longevity, AI, synthetic biology, space, and education.
A pioneer in the longevity industry, Peter has co-founded Fountain Life, Lifeforce, Human Longevity Inc., Cellularity, and Vaxxinity. He is the Founder and Chairman of XPRIZE, which has launched $600M in incentive prizes, driving $30B in R&D, including the $101M XPRIZE Healthspan.
Peter is Co-Founder of BOLD Capital, a venture fund focused on longevity, and Link-XVP, a $1.2B fund investing in AI startups out of MIT and Harvard. He has been named one of the “World’s 50 Greatest Leaders” by Fortune and one of “America’s 250 Greatest Innovators” by Forbes.
He is the host of the Moonshots Podcast and a New York Times bestselling author of six books, including LIFE FORCE and LONGEVITY GUIDEBOOK. He holds degrees in Molecular Genetics and Aerospace Engineering from MIT and an MD from Harvard Medical School.
“I think one day maybe we can cure all disease with the help of AI. Maybe within the next decade or so.”